跳至主要内容
临床试验/NCT06707350
NCT06707350尚未招募不适用

Protective Effect of Remote Ischemic Preconditioning (RIPC) Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery (Panda VII)

Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
500
试验地点
1
主要终点
∆SOFA

研究概览

简要总结

Remote ischaemic pre-conditioning (RIPC) has been recognized as a low-cost, non-invasive intervention method by applying brief ischaemia and reperfusion on an arm or a leg. Previous studies have mainly focused on the organoprotective effects of RIPC in patients undergoing cardiac surgery. However, whether it has an organ-protecting effect is still highly debated. We aimed to determine whether intensive RIPC can prevent from negative inflammatory response and organ dysfunction as well as postoperative complications in patients undergoing cardiovascular surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients at high risk for organ dysfunctions who underwent elective cardiovascular surgery requiring cardiopulmonary bypass (CPB);
  • age of 18 -80 years old, regardless of gender;
  • subjects voluntarily participate in the trialand sign the informed consent;

排除标准

  • Arm fracture, skin injury or infection;
  • There is limb nerve injury;
  • Limb placement PICC, arteriovenous fistula and other devices that affect armband placement;
  • There are basic vascular lesions and poor blood supply at the extremities;
  • Limb thrombosis.

结局指标

主要结局

∆SOFA

时间窗: within the prior 7 days after cardiac surgery.

the change in sequential organ failure assessment score \[∆SOFA\]) was defined as the difference between the mean total postoperative SOFA score, calculated maximally to the 9th postoperative day, and the basal SOFA score.

次要结局

  • Plasma interleukin-1 levels(within the prior 7 days after cardiac surgery.)

研究者

发起方
Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hong Liu

Principal Investigator of China 5A Network

Nanjing Medical University

研究点 (1)

Loading locations...

相似试验